Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 16 (9), 418

Update on Management of Skin and Soft Tissue Infections in the Emergency Department


Update on Management of Skin and Soft Tissue Infections in the Emergency Department

Michael S Pulia et al. Curr Infect Dis Rep.


Skin and soft tissue infections (SSTIs) are frequently treated in the emergency department (ED) setting. Recent studies provide critical new information that can guide new approaches to the diagnosis and treatment of SSTIs in the ED. Rapid polymerase chain reaction assays capable of detecting MRSA in approximately 1 h hold significant potential to improving antibiotic stewardship in SSTI care. Emergency ultrasound continues to demonstrate value in guiding appropriate management of SSTIs, including the early diagnosis of necrotizing infections. Since emerging in the 1990s, community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) continues to increase in prevalence, and it represents a significant challenge to optimizing ED antibiotic use for SSTI management. Growing literature reinforces the current recommendation of incision and drainage without antibiotics for uncomplicated abscesses. Selecting antibiotics with CA-MRSA coverage is recommended when treating purulent SSTIs; however, it is generally not necessary in cases of nonpurulent cellulitis. Future advances in ED SSTI care may involve expansion of outpatient parenteral antimicrobial therapy protocols and the recent development of a novel, once weekly antibiotic with activity against MRSA.

Similar articles

See all similar articles

Cited by 1 article


    1. Am J Emerg Med. 2013 Mar;31(3):632.e5-7 - PubMed
    1. Acad Emerg Med. 2002 Dec;9(12 ):1448-51 - PubMed
    1. J Bone Joint Surg Am. 2003 Aug;85-A(8):1454-60 - PubMed
    1. Infect Control Hosp Epidemiol. 2003 Jun;24(6):431-5 - PubMed
    1. Diagn Microbiol Infect Dis. 2014 Mar;78(3):295-301 - PubMed

LinkOut - more resources